News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
823,553 Results
Type
Article (74824)
Company Profile (646)
Press Release (748082)
Multimedia
Podcasts (141)
Webinars (19)
Section
Business (227643)
Career Advice (3726)
Deals (39353)
Drug Delivery (129)
Drug Development (89490)
Employer Resources (198)
FDA (17943)
Job Trends (17165)
News (388208)
Policy (38855)
Tag
Academia (3001)
Academic (1)
Accelerated approval (12)
Adcomms (32)
Allergies (106)
Alliances (56125)
ALS (120)
Alzheimer's disease (1571)
Antibody-drug conjugate (ADC) (188)
Approvals (17894)
Artificial intelligence (370)
Autoimmune disease (36)
Automation (19)
Bankruptcy (404)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (136)
Biotechnology (440)
Bladder cancer (100)
Brain cancer (41)
Breast cancer (390)
Cancer (3085)
Cardiovascular disease (249)
Career advice (3176)
Career pathing (34)
CAR-T (209)
CDC (41)
Cell therapy (566)
Cervical cancer (24)
Clinical research (73116)
Collaboration (1111)
Company closure (3)
Compensation (713)
Complete response letters (34)
COVID-19 (2904)
CRISPR (67)
C-suite (358)
Cystic fibrosis (121)
Data (3090)
Decentralized trials (2)
Denatured (48)
Depression (76)
Diabetes (378)
Diagnostics (6973)
Digital health (24)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (157)
Drug pricing (151)
Drug shortages (36)
Duchenne muscular dystrophy (136)
Earnings (94768)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (130333)
Executive appointments (909)
FDA (19684)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1008)
Gene editing (147)
Generative AI (32)
Gene therapy (436)
GLP-1 (935)
Government (5212)
Grass and pollen (6)
Guidances (181)
Healthcare (20898)
HIV (45)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (184)
Immuno-oncology (11)
Indications (40)
Infectious disease (3100)
Inflammatory bowel disease (165)
Inflation Reduction Act (13)
Influenza (70)
Intellectual property (125)
Interviews (727)
IPO (17835)
IRA (55)
Job creations (4995)
Job search strategy (2595)
Kidney cancer (14)
Labor market (56)
Layoffs (590)
Leadership (26)
Legal (9938)
Liver cancer (85)
Longevity (12)
Lung cancer (432)
Lymphoma (216)
Machine learning (11)
Management (65)
Manufacturing (437)
MASH (99)
Medical device (14713)
Medtech (14718)
Mergers & acquisitions (22247)
Metabolic disorders (965)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (141)
Neuropsychiatric disorders (42)
Neuroscience (2323)
NextGen: Class of 2025 (7640)
Non-profit (5088)
Now hiring (48)
Obesity (496)
Opinion (291)
Ovarian cancer (104)
Pain (121)
Pancreatic cancer (125)
Parkinson's disease (199)
Partnered (23)
Patents (320)
Patient recruitment (173)
Peanut (55)
People (64508)
Pharmaceutical (133)
Pharmacy benefit managers (25)
Phase I (22604)
Phase II (31894)
Phase III (24029)
Pipeline (1704)
Policy (243)
Postmarket research (3256)
Preclinical (9987)
Press Release (72)
Prostate cancer (150)
Psychedelics (46)
Radiopharmaceuticals (278)
Rare diseases (526)
Real estate (7156)
Recruiting (76)
Regulatory (26461)
Reports (61)
Research institute (2662)
Resumes & cover letters (580)
Rett syndrome (10)
RNA editing (10)
RSV (58)
Schizophrenia (98)
Series A (173)
Series B (118)
Service/supplier (26)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (37)
Startups (4212)
State (2)
Stomach cancer (17)
Supply chain (83)
Tariffs (65)
The Weekly (91)
Vaccines (916)
Venture capital (58)
Weight loss (332)
Women's health (50)
Worklife (20)
Date
Today (93)
Last 7 days (393)
Last 30 days (1964)
Last 365 days (33408)
2025 (18117)
2024 (37898)
2023 (42567)
2022 (53926)
2021 (58723)
2020 (57663)
2019 (51302)
2018 (39084)
2017 (36830)
2016 (37739)
2015 (43730)
2014 (38413)
2013 (34388)
2012 (36287)
2011 (36403)
2010 (35833)
Location
Africa (1193)
Alabama (70)
Alaska (7)
Arizona (260)
Arkansas (14)
Asia (49057)
Australia (8412)
California (7795)
Canada (2416)
China (727)
Colorado (340)
Connecticut (346)
Delaware (203)
Europe (110843)
Florida (1158)
Georgia (264)
Hawaii (2)
Idaho (65)
Illinois (724)
India (32)
Indiana (385)
Iowa (18)
Japan (238)
Kansas (115)
Kentucky (33)
Louisiana (18)
Maine (73)
Maryland (1103)
Massachusetts (5957)
Michigan (273)
Minnesota (484)
Mississippi (3)
Missouri (101)
Montana (32)
Nebraska (26)
Nevada (83)
New Hampshire (72)
New Jersey (2192)
New Mexico (31)
New York (2184)
North Carolina (1239)
North Dakota (10)
Northern California (3365)
Ohio (252)
Oklahoma (17)
Oregon (46)
Pennsylvania (1660)
Puerto Rico (18)
Rhode Island (39)
South America (1566)
South Carolina (36)
South Dakota (1)
Southern California (2887)
Tennessee (129)
Texas (1188)
United States (29353)
Utah (231)
Virginia (212)
Washington D.C. (80)
Washington State (685)
West Virginia (4)
Wisconsin (84)
823,553 Results for "otsuka pharmaceutical co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IgA nephropathy
Otsuka Sees ‘Impressive’ Proteinuria Reduction in Phase III IgAN Trial
Otsuka’s investigational antibody sibeprenlimab approximately halved levels of this key biomarker in patients with immunoglobulin A nephropathy.
June 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Cantargia Announces the Acquisition of its CAN10 IL1RAP Immunology Program by Otsuka Pharmaceutical
July 15, 2025
·
4 min read
Press Releases
Harbour BioMed Enters Global Strategic Collaboration with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers
June 23, 2025
·
4 min read
Pharm Country
Otsuka to Terminate Development of AVP-786
Otsuka Pharmaceutical Co., Ltd. and its U.S. subsidiary, Otsuka Pharmaceutical Development & Commercialization, Inc. announce termination of development of the novel compound AVP-786, which was in development as a potential treatment for patients with agitation associated with dementia due to Alzheimer’s disease.
May 22, 2024
·
2 min read
Press Releases
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
May 1, 2025
·
7 min read
Press Releases
Univar Solutions and Shandong Head Group Co., Ltd. Establish Exclusive European Partnership to Enhance Supply of Cellulose Ethers and Pharmaceutical Excipients
May 22, 2025
·
7 min read
Biotech Beach
Ionis announces expanded licensing agreement with Otsuka in Asia Pacific for investigational medicine donidalorsen in hereditary angioedema
Ionis Pharmaceuticals, Inc. announced that it has entered into a license agreement with Otsuka Pharmaceutical Co., Ltd. under which Otsuka obtains exclusive rights across the Asia-Pacific region for donidalorsen, an investigational RNA-targeted prophylactic medicine for hereditary angioedema.
June 18, 2024
·
5 min read
Sponsored
Taipei City Government Partners With Six Biotech Companies to Showcase at BIO International Convention 2025
The 2025 BIO International Convention (BIO2025), the world’s largest annual biotech event, will take place from June 16 to 19 (U.S. time) at the Boston Convention & Exhibition Center. This year, Taipei City Government is partnering with six Taipei-based biotech companies, including PanCAD.ai Co., Ltd., Instant NanoBiosensors Co., Ltd., Bened Biomedical Co., Ltd., Cancer Free Biotech Ltd., Xantho Biotechnology Co., Ltd., and Energenesis Biomedical Co., Ltd., to showcase their innovations at the Taiwan Pavilion (Booth #1645) in the Taipei Exhibition Area.
June 16, 2025
·
5 min read
Business
Otsuka and Click Therapeutics Announce the U.S. Food and Drug Administration (FDA) Clearance of Rejoyn
Otsuka Pharmaceutical, Co. Ltd. (Otsuka) and Click Therapeutics, Inc., (Click) announce that the U.S. Food and Drug Administration (FDA) has cleared Rejoyn.
April 1, 2024
·
12 min read
Press Releases
Otsuka Sibeprenlimab Phase 3 Data Show a Statistically Significant and Clinically Meaningful Proteinuria Reduction for the Treatment of Immunoglobulin A Nephropathy (IgAN)
June 6, 2025
·
10 min read
1 of 82,356
Next
